SMARCB1 and epithelioid sarcoma: In epithelioid sarcoma, the sensitivity to tazemetostat is associated with a loss of SMARCB1, a component of the SWI/SNF remodeling complex of Trithorax group (TrxG) proteins that antagonize PcG repression [27].